Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Synthonics, Inc. logo — Innovative pharmaceutical solutions enhancing absorption and...

Synthonics, Inc.

Innovative pharmaceutical solutions enhancing absorption and maximizing therapeutic benefits through proprietary metal coordination chemistry.

Founded 2006 United States Blacksburg, United States 11 employees Venture round Total: $3.10M Biotechnology, Pharmaceutical

General Information

Company Name Synthonics, Inc.
Founded Year 2006
Location United States Blacksburg, United States
Employees 11
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Synthonics, Inc.. To contact Synthonics, Inc., visit synthonicsinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Synthonics, Inc. compare?

A PDF of Synthonics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Synthonics, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Synthonics, Inc.

Synthonics, Inc. is a privately-held specialty pharmaceutical company revolutionizing the industry through their innovative pharmaceutical solutions. Utilizing proprietary metal coordination chemistry, the company focuses on the discovery and development of patentable drugs with the aim of enhancing absorption and maximizing therapeutic benefits. Founded in 1993, their groundbreaking approach involves binding metals to existing pharmaceutical agents to create new products that offer significantly improved absorption and enhanced therapeutic benefits compared to their predecessors. Their most recent milestone was a $500.00K Venture Round investment on 05 August 2014, demonstrating the continued interest and confidence from the investment community in their unique approach. With their headquarters in the United States, Synthonics operates at the forefront of the Biotechnology and Pharmaceutical industries, positioned to make a lasting impact on the future of pharmaceuticals.

Business keywords: pharmaceuticals, drug discovery, metal coordination chemistry, therapeutic benefits, proprietary technology, absorption enhancement

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $500.00K -
05 Aug 2014
Venture Round $2.60M -
30 Nov 2010

Synthonics, Inc. Alternatives & Competitors

View All Alternatives
Synthonics, Inc. vs
Phytomedics Inc
Phytomedics Inc

Phytomedics mission is to discover, develop and manufacture novel multi-mechanism / multi-component...

Series B
5 employees
Biotechnology, Manufacturing
Synthonics, Inc. vs
Advenchen Laboratories, LLC
Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...

Venture round
6 employees
Biotechnology, Health Care
Synthonics, Inc. vs
Entera Bio Ltd.
Entera Bio Ltd.

Developing innovative oral delivery of therapeutic proteins.

Post-IPO Equity
19 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Synthonics, Inc.

Innovative pharmaceutical solutions enhancing absorption and maximizing therapeutic benefits through proprietary metal coordination chemistry.
Synthonics, Inc. was founded in 2006.
Synthonics, Inc. is headquartered in Blacksburg, United States.
Synthonics, Inc. operates in Biotechnology and Pharmaceutical. Its work centres on pharmaceuticals, drug discovery, metal coordination chemistry and therapeutic benefits.
Synthonics, Inc. has approximately 11 employees.
Synthonics, Inc. has completed 2 funding rounds, raising a total of $3.10M. The latest funding stage is Venture round.
Top alternatives and competitors to Synthonics, Inc. include Phytomedics Inc, Advenchen Laboratories, LLC, Entera Bio Ltd., Taros Discovery, Lanthio Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synthonics, Inc. and Phytomedics Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Synthonics, Inc., https://bouncewatch.com/company/synthonics-inc, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes